The CEOs of Johnson & Johnson, Merck, and Bristol Myers Squibb have agreed to voluntarily testify at a Senate hearing in February regarding high prescription drug prices in the US, negating the need for a planned subpoena. This decision came following Senator Bernie Sanders’s criticism of the executives for their initial refusal due to claimed lack of expertise.
Deploying AI-powered solutions can save lives through enriching disease screenings
Artificial intelligence (AI) could improve care quality and patient identification, reducing the cost of chronic disease management, which accounts for 90% of America’s $4.1tn yearly